Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person3
Glucotrack, Inc.
Company
Track Group, Inc.
Company
GRACO INC
Company
Primary record20
Glucotrack, Inc. filed 8-K
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, Glucotrack, Inc. (the “Company”) received a determination from The Nasdaq Stock Mark
Glucotrack, Inc. filed 8-K
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Glucotrack, Inc., a Delaware corporation (the “Company”), filed with the Delaware Secretary of State a Certificate of Amendment to the Ce
Glucotrack, Inc. filed 8-K
Item 1.01. Entry Into a Material Definitive Agreement. Private Placement On October 22, 2026, Glucotrack, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain investor
Glucotrack, Inc. filed 8-K
Item 1.01. Entry Into a Material Definitive Agreement. On October 13, 2026, Glucotrack, Inc. (the “Company”) entered into a Waiver Agreement (the “Waiver”) with certain holders (the “Holders”) of warrants to purchase sha
Glucotrack, Inc. filed S-1/A
SEC form S-1/A filed by Glucotrack, Inc. (CIK 1506983) on 2026-10-14.
Glucotrack, Inc. filed 8-K
Item 1.01. Entry Into a Material Definitive Agreement. As previously disclosed, on July 14, 2026, Glucotrack, Inc. (the Company ) entered into a securities purchase agreement as supplemented by a joinder dated August 4,
Glucotrack, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On September 24, 2026, Glucotrack, Inc., a Delaware corporation (the Company ), entered into a securities purchase agreement (the Purchase Agreement ) with certain in
Glucotrack, Inc. filed 8-K
Item 7.01. Regulation FD Disclosure. On September 23, 2026, Glucotrack, Inc., a Delaware corporation (the Company ), issued a shareholder update. The update is furnished as Exhibit 99.1. The information in this Item 7.01
Glucotrack, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 14, 2026, Paul V. Goode notified the Board of Dir
Glucotrack, Inc. filed S-1
SEC form S-1 filed by Glucotrack, Inc. (CIK 1506983) on 2026-09-18.
Glucotrack, Inc. filed 8-K
Item 1.01. Entry Into a Material Definitive Agreement. As previously disclosed, on August 4, 2026, Glucotrack, Inc. (the Company ) entered into a securities purchase agreement with an investor (the PIPE Purchaser ) for a
Glucotrack, Inc. filed 8-K
Item 1.01. Entry Into a Material Definitive Agreement. Private Placement On September 10, 2026, Glucotrack, Inc. (the Company ) entered into a securities purchase agreement (the Purchase Agreement ) with certain investor
Glucotrack, Inc. filed 8-K
Item 1.01 Entry Into a Material Definitive Agreement. On September 4, 2026, Glucotrack, Inc. (the Company ) entered into a Settlement and Release Agreement (the Settlement Agreement ) with Alto Opportunity Master Fund, S
Glucotrack, Inc. filed SCHEDULE 13G
, as amended (the "Exchange Act"), or for any other purpose. (2) Calculated in accordance with Rule 13d-3 promulgated under the Exchange Act and based on 798,144 shares of Common Stock outstanding as of August 28, 2026.
Glucotrack, Inc. filed 8-K
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Glucotrack, Inc., a Delaware corporation (the Company ), filed with the Delaware Secretary of State a Certificate of Amendment to the Cer
Glucotrack, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure On August 27, 2026, Glucotrack, Inc., a Delaware corporation (the Company ), issued a press release (the Press Release ), which announced a 1-for-15 reverse stock split of the Company s
Glucotrack, Inc. filed 8-K
Item 5.07. Submission of Matters to a Vote of Security Holders. Summary of Proposals Submitted to Stockholders On August 18, 2026, Glucotrack, Inc. (the Company ) held its 2026 annual meeting of stockholders (the Annual
FingerMotion, Inc. filed 8-K
Item 5.02 Departure of an Executive Officer and Director; Appointment of an Executive Officer and Director On August 4, 2026, Martin Shen resigned as Chief Executive Officer and Director of FingerMotion, Inc. (the “Compa
Glucotrack, Inc. filed 8-K
Item 1.01 Entry Into A Material Definitive Agreement. On August 7, 2026, Glucotrack, Inc. (the “Company”) entered into Amendment No. 1 (the “Amendment”) to the Common Stock Purchase Agreement, dated July 14, 2026 (the “E
Glucotrack, Inc. filed DEF 14A
SEC form DEF 14A filed by Glucotrack, Inc. (CIK 1506983) on 2026-08-10.